Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 181 to 192 of 206 entries
Sorted by: Best Match Show Resources per page
[Cytoprotection in Cardiology: Achievements and Prospects].

Kardiologiia

Mikhin VP.
PMID: 28294801
Kardiologiia. 2015 Oct;55(10):90-95. doi: 10.18565/cardio.2015.10.90-95.

Currently, pharmacotherapy of coronary heart disease, based on antianginal drugs directly improve coronary blood flow, antiplatelet, and lipid-lowering drugs, includes a new class of drugs - cardiocytoprotectors. Recent ischemic cardiomyocytes improve security in the ATP, by optimizing the energy...

Cite
Mikhin VP. [Cytoprotection in Cardiology: Achievements and Prospects]. Kardiologiia. 2015;55(10):90-95doi: 10.18565/cardio.2015.10.90-95.
Mikhin, V. P. (2015). [Cytoprotection in Cardiology: Achievements and Prospects]. Kardiologiia, 55(10), 90-95. https://doi.org/10.18565/cardio.2015.10.90-95
Mikhin, V P. "[Cytoprotection in Cardiology: Achievements and Prospects]." Kardiologiia vol. 55,10 (2015): 90-95. doi: https://doi.org/10.18565/cardio.2015.10.90-95
Mikhin VP. [Cytoprotection in Cardiology: Achievements and Prospects]. Kardiologiia. 2015 Oct;55(10):90-95. doi: 10.18565/cardio.2015.10.90-95. Russian. PMID: 28294801.
Copy Download .nbib Format: NLM
[Type of Thrombolytic Agent and Rate of Acute Kidney Injury in Patients With Myocardial Infarction].

Kardiologiia

Menzorov MV, Shutov AM, Serov VA, Saenko YV, Grishenkin IY.
PMID: 28294805
Kardiologiia. 2015 Feb;55(2):16-20.

Aim of this study was to assess incidence and severity of acute kidney injury (AKI) in patients with ST-elevation (STE) myocardial infarction (MI) after thrombolytic therapy with alteplase or streptokinase. Among 292 included patients (227 men, 65 women, mean...

Cite
Menzorov MV, Shutov AM, Serov VA, et al. [Type of Thrombolytic Agent and Rate of Acute Kidney Injury in Patients With Myocardial Infarction]. Kardiologiia. 2015;55(2):16-20
Menzorov, M. V., Shutov, A. M., Serov, V. A., Saenko, Y. V., & Grishenkin, I. Y. (2015). [Type of Thrombolytic Agent and Rate of Acute Kidney Injury in Patients With Myocardial Infarction]. Kardiologiia, 55(2), 16-20.
Menzorov, M V, et al. "[Type of Thrombolytic Agent and Rate of Acute Kidney Injury in Patients With Myocardial Infarction]." Kardiologiia vol. 55,2 (2015): 16-20.
Menzorov MV, Shutov AM, Serov VA, Saenko YV, Grishenkin IY. [Type of Thrombolytic Agent and Rate of Acute Kidney Injury in Patients With Myocardial Infarction]. Kardiologiia. 2015 Feb;55(2):16-20. Russian. PMID: 28294805.
Copy Download .nbib Format: NLM
[Plasma Renin Activity and Potential of Indapamide Retard to Improve Control of Hypertension].

Kardiologiia

Kobalava ZD, Kotovskaya YV, Kravtsova OA.
PMID: 28294806
Kardiologiia. 2015 Feb;55(2):21-26.

PURPOSE: to study plasma renin activity (PRA) as a predictor of antihypertensive response to addition of diuretic to combination of angiotensin-converting enzyme inhibitor (ACEI) and calcium antagonist (CA).MATERIAL AND METHODS: The study included 72 patients (39% men, mean age...

Cite
Kobalava ZD, Kotovskaya YV, Kravtsova OA. [Plasma Renin Activity and Potential of Indapamide Retard to Improve Control of Hypertension]. Kardiologiia. 2015;55(2):21-26
Kobalava, Z. D., Kotovskaya, Y. V., & Kravtsova, O. A. (2015). [Plasma Renin Activity and Potential of Indapamide Retard to Improve Control of Hypertension]. Kardiologiia, 55(2), 21-26.
Kobalava, Zh D, et al. "[Plasma Renin Activity and Potential of Indapamide Retard to Improve Control of Hypertension]." Kardiologiia vol. 55,2 (2015): 21-26.
Kobalava ZD, Kotovskaya YV, Kravtsova OA. [Plasma Renin Activity and Potential of Indapamide Retard to Improve Control of Hypertension]. Kardiologiia. 2015 Feb;55(2):21-26. Russian. PMID: 28294806.
Copy Download .nbib Format: NLM
[Scientific Conference A New Era in the Treatment of Acute Decompensated Heart Failure: Focus on Innovation].

Kardiologiia

Ostrovskaya OV.
PMID: 28294830
Kardiologiia. 2015 Jan;55(1):62-63. doi: 10.18565/cardio.2015.1.62-63.

11 oktyabrya v Sankt-Peterburge sostoyalas Nauchnaya konferenciya, posvyashennaya podrobnomu analizu situacii v rossiiskom zdravoohranenii v sfere diagnostiki i lecheniya ostroi serdechnoi nedostatochnosti. V konferencii prinyali uchastie vedushie kardiologi Rossii pod predsedatelstvom prezidenta Rossiiskogo kardiologicheskogo obshestva, akademika RAN Evgeniya Vladimirovicha...

Cite
Ostrovskaya OV. [Scientific Conference A New Era in the Treatment of Acute Decompensated Heart Failure: Focus on Innovation]. Kardiologiia. 2015;55(1):62-63doi: 10.18565/cardio.2015.1.62-63.
Ostrovskaya, O. V. (2015). [Scientific Conference A New Era in the Treatment of Acute Decompensated Heart Failure: Focus on Innovation]. Kardiologiia, 55(1), 62-63. https://doi.org/10.18565/cardio.2015.1.62-63
Ostrovskaya, O V. "[Scientific Conference A New Era in the Treatment of Acute Decompensated Heart Failure: Focus on Innovation]." Kardiologiia vol. 55,1 (2015): 62-63. doi: https://doi.org/10.18565/cardio.2015.1.62-63
Ostrovskaya OV. [Scientific Conference A New Era in the Treatment of Acute Decompensated Heart Failure: Focus on Innovation]. Kardiologiia. 2015 Jan;55(1):62-63. doi: 10.18565/cardio.2015.1.62-63. Russian. PMID: 28294830.
Copy Download .nbib Format: NLM
[What We Know About Acute Decompensation of Heart Failure?].

Kardiologiia

Tereshchenko SN, Zhirov IV, Nasonova SN.
PMID: 28294903
Kardiologiia. 2015 Apr;55(4):91-96.

No abstract available.

Cite
Tereshchenko SN, Zhirov IV, Nasonova SN. [What We Know About Acute Decompensation of Heart Failure?]. Kardiologiia. 2015;55(4):91-96
Tereshchenko, S. N., Zhirov, I. V., & Nasonova, S. N. (2015). [What We Know About Acute Decompensation of Heart Failure?]. Kardiologiia, 55(4), 91-96.
Tereshchenko, S N, et al. "[What We Know About Acute Decompensation of Heart Failure?]." Kardiologiia vol. 55,4 (2015): 91-96.
Tereshchenko SN, Zhirov IV, Nasonova SN. [What We Know About Acute Decompensation of Heart Failure?]. Kardiologiia. 2015 Apr;55(4):91-96. Russian. PMID: 28294903.
Copy Download .nbib Format: NLM
[Azilsartan: Whether it Will Expand Treatment Options for Hypertension?].

Kardiologiia

Nedogoda SV.
PMID: 28294904
Kardiologiia. 2015 Apr;55(4):97-100.

No abstract available.

Cite
Nedogoda SV. [Azilsartan: Whether it Will Expand Treatment Options for Hypertension?]. Kardiologiia. 2015;55(4):97-100
Nedogoda, S. V. (2015). [Azilsartan: Whether it Will Expand Treatment Options for Hypertension?]. Kardiologiia, 55(4), 97-100.
Nedogoda, S V. "[Azilsartan: Whether it Will Expand Treatment Options for Hypertension?]." Kardiologiia vol. 55,4 (2015): 97-100.
Nedogoda SV. [Azilsartan: Whether it Will Expand Treatment Options for Hypertension?]. Kardiologiia. 2015 Apr;55(4):97-100. Russian. PMID: 28294904.
Copy Download .nbib Format: NLM
[The State of Hemostasis and Immune System in Patients With Acute Coronary Syndrome Combined With Anxiety-Depressive Disorder].

Kardiologiia

Shimohina NY, Savchenko AA, Petrova MM, Chernyaeva Pilyugina MS.
PMID: 28294914
Kardiologiia. 2015 Aug;55(8):12-20.

Anxiety-depressive disorders (DD) have a negative impact on the course and prognosis of patients with ischemic heart disease, but the mechanisms of their correlation are not studied enough. The purpose of this study was to elucidate special characteristics of...

Cite
Shimohina NY, Savchenko AA, Petrova MM, et al. [The State of Hemostasis and Immune System in Patients With Acute Coronary Syndrome Combined With Anxiety-Depressive Disorder]. Kardiologiia. 2015;55(8):12-20
Shimohina, N. Y., Savchenko, A. A., Petrova, M. M., & Chernyaeva Pilyugina, M. S. (2015). [The State of Hemostasis and Immune System in Patients With Acute Coronary Syndrome Combined With Anxiety-Depressive Disorder]. Kardiologiia, 55(8), 12-20.
Shimohina, N Yu, et al. "[The State of Hemostasis and Immune System in Patients With Acute Coronary Syndrome Combined With Anxiety-Depressive Disorder]." Kardiologiia vol. 55,8 (2015): 12-20.
Shimohina NY, Savchenko AA, Petrova MM, Chernyaeva Pilyugina MS. [The State of Hemostasis and Immune System in Patients With Acute Coronary Syndrome Combined With Anxiety-Depressive Disorder]. Kardiologiia. 2015 Aug;55(8):12-20. Russian. PMID: 28294914.
Copy Download .nbib Format: NLM
[Some Aspects of Formation of Chronic Heart Failure in Patients With Chronic Obstructive Pulmonary Disease].

Kardiologiia

Karoli NA, Borodkin AV, Rebrov AP.
PMID: 28290885
Kardiologiia. 2016 Aug;56(8):73-80. doi: 10.18565/cardio.2016.8.73-80.

No abstract available.

Cite
Karoli NA, Borodkin AV, Rebrov AP. [Some Aspects of Formation of Chronic Heart Failure in Patients With Chronic Obstructive Pulmonary Disease]. Kardiologiia. 2016;56(8):73-80doi: 10.18565/cardio.2016.8.73-80.
Karoli, N. A., Borodkin, A. V., & Rebrov, A. P. (2016). [Some Aspects of Formation of Chronic Heart Failure in Patients With Chronic Obstructive Pulmonary Disease]. Kardiologiia, 56(8), 73-80. https://doi.org/10.18565/cardio.2016.8.73-80
Karoli, N A, et al. "[Some Aspects of Formation of Chronic Heart Failure in Patients With Chronic Obstructive Pulmonary Disease]." Kardiologiia vol. 56,8 (2016): 73-80. doi: https://doi.org/10.18565/cardio.2016.8.73-80
Karoli NA, Borodkin AV, Rebrov AP. [Some Aspects of Formation of Chronic Heart Failure in Patients With Chronic Obstructive Pulmonary Disease]. Kardiologiia. 2016 Aug;56(8):73-80. doi: 10.18565/cardio.2016.8.73-80. Russian. PMID: 28290885.
Copy Download .nbib Format: NLM
[Arterial Hypertension Complicated by Myocardial Hypertrophy and Heart Failure Is Associated With Lower Serum Levels of Vascular Endothelium Growth Factor (VEGF-A165)].

Kardiologiia

Chumakova OS, Tipteva TA, Resnichenko NE, Zateyshchikov DA.
PMID: 28294789
Kardiologiia. 2015 Oct;55(10):14-18. doi: 10.18565/cardio.2015.10.14-18.

AIM: To study relationships of serum levels of vascular endothelium growth factor with left ventricular (LV) myocardial hypertrophy (H) and signs of heart failure (HF) in patients with arterial hypertension (AH).METHODS: We examined 47 patients with AH and by...

Cite
Chumakova OS, Tipteva TA, Resnichenko NE, et al. [Arterial Hypertension Complicated by Myocardial Hypertrophy and Heart Failure Is Associated With Lower Serum Levels of Vascular Endothelium Growth Factor (VEGF-A165)]. Kardiologiia. 2015;55(10):14-18doi: 10.18565/cardio.2015.10.14-18.
Chumakova, O. S., Tipteva, T. A., Resnichenko, N. E., & Zateyshchikov, D. A. (2015). [Arterial Hypertension Complicated by Myocardial Hypertrophy and Heart Failure Is Associated With Lower Serum Levels of Vascular Endothelium Growth Factor (VEGF-A165)]. Kardiologiia, 55(10), 14-18. https://doi.org/10.18565/cardio.2015.10.14-18
Chumakova, O S, et al. "[Arterial Hypertension Complicated by Myocardial Hypertrophy and Heart Failure Is Associated With Lower Serum Levels of Vascular Endothelium Growth Factor (VEGF-A165)]." Kardiologiia vol. 55,10 (2015): 14-18. doi: https://doi.org/10.18565/cardio.2015.10.14-18
Chumakova OS, Tipteva TA, Resnichenko NE, Zateyshchikov DA. [Arterial Hypertension Complicated by Myocardial Hypertrophy and Heart Failure Is Associated With Lower Serum Levels of Vascular Endothelium Growth Factor (VEGF-A165)]. Kardiologiia. 2015 Oct;55(10):14-18. doi: 10.18565/cardio.2015.10.14-18. Russian. PMID: 28294789.
Copy Download .nbib Format: NLM
[Pharmacoepidemiology of Statins in Patients With Hypertension and Dyslipidemia].

Kardiologiia

Ponomareva AI, Kompaniets OG, Linchak RM, Agafonova GA.
PMID: 28294791
Kardiologiia. 2015 Oct;55(10):25-31. doi: 10.18565/cardio.2015.10.25-31.

Aim of the study was to analyze the validity of pharmacoepidemiological purpose and structure of lipid-lowering therapy (LLT) in patients with hypertension and dyslipidemia in clinical practice. Demonstrated commitment to the basic principles of medical verification of cardiovascular events...

Cite
Ponomareva AI, Kompaniets OG, Linchak RM, et al. [Pharmacoepidemiology of Statins in Patients With Hypertension and Dyslipidemia]. Kardiologiia. 2015;55(10):25-31doi: 10.18565/cardio.2015.10.25-31.
Ponomareva, A. I., Kompaniets, O. G., Linchak, R. M., & Agafonova, G. A. (2015). [Pharmacoepidemiology of Statins in Patients With Hypertension and Dyslipidemia]. Kardiologiia, 55(10), 25-31. https://doi.org/10.18565/cardio.2015.10.25-31
Ponomareva, A I, et al. "[Pharmacoepidemiology of Statins in Patients With Hypertension and Dyslipidemia]." Kardiologiia vol. 55,10 (2015): 25-31. doi: https://doi.org/10.18565/cardio.2015.10.25-31
Ponomareva AI, Kompaniets OG, Linchak RM, Agafonova GA. [Pharmacoepidemiology of Statins in Patients With Hypertension and Dyslipidemia]. Kardiologiia. 2015 Oct;55(10):25-31. doi: 10.18565/cardio.2015.10.25-31. Russian. PMID: 28294791.
Copy Download .nbib Format: NLM
[Biomarkers in Heart Failure: Apelin Level Is not Associated With Presence and Severity of the Disease].

Kardiologiia

Lakomkin SV, Tereshchenko SN, Sychev AV, Masenko VP, G TA, Gerasimova ON, Sigalovich EY, Dankovtseva EN, Zateyshchikov DA.
PMID: 28294809
Kardiologiia. 2015 Feb;55(2):37-41.

We tested possibility of the use of apelin-12 as a biomarker of chronic heart failure (CHF). The study comprised 108 patients with I-IV functional class CHF of various etiology (ischemic heart disease, dilation cardiomyopathy) and 40 healthy volunteers. Blood...

Cite
Lakomkin SV, Tereshchenko SN, Sychev AV, et al. [Biomarkers in Heart Failure: Apelin Level Is not Associated With Presence and Severity of the Disease]. Kardiologiia. 2015;55(2):37-41
Lakomkin, S. V., Tereshchenko, S. N., Sychev, A. V., Masenko, V. P., G, T. A., Gerasimova, O. N., Sigalovich, E. Y., Dankovtseva, E. N., & Zateyshchikov, D. A. (2015). [Biomarkers in Heart Failure: Apelin Level Is not Associated With Presence and Severity of the Disease]. Kardiologiia, 55(2), 37-41.
Lakomkin, S V, et al. "[Biomarkers in Heart Failure: Apelin Level Is not Associated With Presence and Severity of the Disease]." Kardiologiia vol. 55,2 (2015): 37-41.
Lakomkin SV, Tereshchenko SN, Sychev AV, Masenko VP, G TA, Gerasimova ON, Sigalovich EY, Dankovtseva EN, Zateyshchikov DA. [Biomarkers in Heart Failure: Apelin Level Is not Associated With Presence and Severity of the Disease]. Kardiologiia. 2015 Feb;55(2):37-41. Russian. PMID: 28294809.
Copy Download .nbib Format: NLM
[Prediction of Subclinical Carotid Atherosclerosis With Parameters of Negative for Ischemia Exercise Testing].

Kardiologiia

Katamadze NO, Berstein LL, Grishkin YN.
PMID: 28294810
Kardiologiia. 2015 Feb;55(2):42-48.

AIM: to elucidate relationship between parameters of negative ischemic stress test and subclinical atherosclerosis of carotid arteries.MATERIAL AND METHODS: Electrocardiographic stress test on treadmill and ultrasound study of carotid arteries (CA) were carried out in 204 patients (100women and...

Cite
Katamadze NO, Berstein LL, Grishkin YN. [Prediction of Subclinical Carotid Atherosclerosis With Parameters of Negative for Ischemia Exercise Testing]. Kardiologiia. 2015;55(2):42-48
Katamadze, N. O., Berstein, L. L., & Grishkin, Y. N. (2015). [Prediction of Subclinical Carotid Atherosclerosis With Parameters of Negative for Ischemia Exercise Testing]. Kardiologiia, 55(2), 42-48.
Katamadze, N O, et al. "[Prediction of Subclinical Carotid Atherosclerosis With Parameters of Negative for Ischemia Exercise Testing]." Kardiologiia vol. 55,2 (2015): 42-48.
Katamadze NO, Berstein LL, Grishkin YN. [Prediction of Subclinical Carotid Atherosclerosis With Parameters of Negative for Ischemia Exercise Testing]. Kardiologiia. 2015 Feb;55(2):42-48. Russian. PMID: 28294810.
Copy Download .nbib Format: NLM
Showing 181 to 192 of 206 entries